Twinaqt 50/300 Tablet 30's
₹3424.3*
MRP ₹4176
18% off
₹3550*
MRP ₹4176
15% CB
₹626 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Twinaqt 50/300 Tablet belongs to a class of drugs called antiretrovirals used to treat HIV infection. Twinaqt 50/300 Tablet helps decrease the chance of developing AIDS (acquired immunodeficiency syndrome). HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and destroys the white blood cells that help fight infection, making the individual susceptible to other infections or illnesses.
Twinaqt 50/300 Tablet contains Dolutegravir and Lamivudine. Both Dolutegravir and Lamivudine are nucleoside reverse transcriptase inhibitors. Twinaqt 50/300 Tablet works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes necessary for virus reproduction. Together, Twinaqt 50/300 Tablet helps treat HIV infections.
Twinaqt 50/300 Tablet is a prescription medication. You should take this medicine exactly as prescribed by the doctor. The common side effects of Twinaqt 50/300 Tablet are nausea, headache, tiredness, diarrhoea, dizziness, anxiety, gas, difficulty falling asleep or staying asleep and muscle weakness. Most of these side effects of Twinaqt 50/300 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Twinaqt 50/300 Tablet is not recommended to take Twinaqt 50/300 Tablet if you are allergic to any of its contents. Twinaqt 50/300 Tablet is not recommended for use in children and adolescents under 18 years of age. Twinaqt 50/300 Tablet may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy. Consumption of alcohol may increase the risk of side effects; therefore, avoid alcohol consumption. You should not become pregnant while you are taking Twinaqt 50/300 Tablet . Talk to your doctor about effective birth control methods that you can use during your treatment. If you become pregnant while taking Twinaqt 50/300 Tablet , call your doctor immediately. You should not breastfeed if you are infected with HIV or if you are taking Twinaqt 50/300 Tablet .
Twinaqt 50/300 Tablet is a combination of two drugs, Dolutegravir and Lamivudine, used to treat HIV infection. Both Dolutegravir and Lamivudine are nucleoside reverse transcriptase inhibitors. Twinaqt 50/300 Tablet interferes with the working of nucleotide and nucleoside reverse transcriptase enzymes necessary for virus reproduction. Thus, Twinaqt 50/300 Tablet helps treat HIV infections. Taking Twinaqt 50/300 Tablet along with practising safe sex and lifestyle changes may reduce the risk of getting or transmitting HIV to others.
Talk to your doctor about the risks and benefits of taking Twinaqt 50/300 Tablet . Before taking the Twinaqt 50/300 Tablet , inform your doctor about all your medical conditions, sensitivities, and medications you are using. Twinaqt 50/300 Tablet is not recommended for children below 18 years of age. You are advised to take proper precautions if you are infected with HIV to prevent infection from spreading to others through sexual contact or body fluids. If you have HBV and you take Twinaqt 50/300 Tablet , your condition may suddenly worsen when you stop taking Twinaqt 50/300 Tablet . Tell your doctor if you have or suspect you have hepatitis B virus infection (HBV; a continuous liver infection). Your doctor may test you to see if you have HBV before you start therapy with Twinaqt 50/300 Tablet . You are recommended to avoid alcohol consumption with Twinaqt 50/300 Tablet . Drive only if you are alert, as Twinaqt 50/300 Tablet may cause dizziness.
Drug-Drug Interactions: Twinaqt 50/300 Tablet may interact with other antiviral medications (e.g. emtricitabine, tenofovir alafenamide), oral iron bivalent preparations (e.g. ferrous fumarate, ferrous sulfate), certain mineral supplements (zinc sulfate), anticancer medications (e.g. bexarotene, pexidartinib), HIV medications (e.g. emtricitabine, zalcitabine), and antirheumatic drugs (e.g. leflunomide).
Drug-Food Interactions: Twinaqt 50/300 Tablet may interact with alcohol and alcohol-containing beverages. Therefore, avoid alcohol intake and Twinaqt 50/300 Tablet as it may increase the risk of adverse effects.
Drug-Disease Interactions: Twinaqt 50/300 Tablet may interact with disease conditions, including hepatotoxicity (injury to the liver or impairment of the liver function), pancreatitis, renal dysfunction, or hemodialysis (a treatment to filter waste and water from your blood).
Attend every appointment with your doctor and laboratory. Your doctor will ask for tests to evaluate your body's response to dolutegravir and lamivudine.
HIV infection: HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and destroys the white blood cells that help fight infection, making the individual susceptible to other infections or illnesses. People with HIV experience flu-like symptoms such as fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat. These symptoms usually last for days to several weeks. HIV spreads through body fluids such as semen, vaginal fluid, and blood. If left untreated, this condition can lead to AIDS (acquired immunodeficiency syndrome). It is a life-long condition, and there is no definite cure. However, it can be controlled by treating it with antiretroviral drugs.
Alcohol
Unsafe
Consumption of alcohol should be avoided.
Pregnancy
Unsafe
Twinaqt 50/300 Tablet is not suggested during pregnancy. You should not become pregnant while you are taking Twinaqt 50/300 Tablet . Ask your doctor about effective birth control options that you can use during your therapy. If you become pregnant while taking Twinaqt 50/300 Tablet , call your doctor right away.
Breast Feeding
Unsafe
You should not breastfeed if you are infected with HIV or if you are taking Twinaqt 50/300 Tablet .
Driving
Caution
Twinaqt 50/300 Tablet may cause dizziness in some people. Therefore, avoid driving or operating heavy machinery if you feel dizzy after taking Twinaqt 50/300 Tablet .
Liver
Caution
Take Twinaqt 50/300 Tablet with caution, especially if you have a history of liver diseases. Inform your doctor if you have liver impairment. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
Take Twinaqt 50/300 Tablet with caution, especially if you have a history of Kidney diseases/conditions. Your doctor will prescribe only if the benefits outweigh the risks.
Children
Unsafe
Twinaqt 50/300 Tablet is not recommended for children below 18 years of age.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information